Difference between revisions of "Template:Drugs for peptic ulcer and GORD"
Jump to navigation
Jump to search
imported>Julthep |
(fix redirect, clarify acronyms) |
||
Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
− | | name | + | |name = Drugs for peptic ulcer and GORD |
− | | title = | + | |title= drugs for [[peptic ulcer]] and [[Gastroesophageal reflux disease|gastroesophageal reflux disease (GERD / GORD)]] — ([[ATC code A02#A02B|A02B]]) |
− | + | |listclass= hlist | |
− | |listclass = hlist | ||
− | | group1 = [[H2 antagonist|H<sub>2</sub> antagonists]] ( | + | |group1= [[H2 antagonist|H<sub>2</sub> antagonists]] ('-tidine') |
− | | | + | |list1= |
− | * [[Cimetidine]] | + | *[[Cimetidine]] |
− | * [[Famotidine]] | + | *[[Famotidine]] |
− | * [[Lafutidine]] | + | *[[Lafutidine]] |
− | * [[Lavoltidine|Lavoltidine (loxtidine)]] | + | *[[Lavoltidine|Lavoltidine (loxtidine)]] |
− | * [[Niperotidine]] | + | *[[Niperotidine]] |
− | * [[Nizatidine]] | + | *[[Nizatidine]] |
− | * [[Ranitidine]]<sup>#</sup> | + | *[[Ranitidine]]<sup>#</sup> |
− | * [[Roxatidine]] | + | *[[Roxatidine acetate|Roxatidine]] |
− | | group2 = [[ | + | |group2= [[prostaglandin]]s (E) / [[Prostaglandin analogue|analogue]]s ('-prost-') |
− | | | + | |list2= |
− | * [[Misoprostol]] | + | *[[Misoprostol]] |
− | * [[Enprostil]] | + | *[[Enprostil]] |
− | | group3 = [[Proton-pump inhibitor]] | + | |group3= [[Proton-pump inhibitor|proton-pump inhibitors (PPIs)]] ('-prazole') |
− | | | + | |list3= |
− | * [[Azeloprazole]] | + | *[[Azeloprazole]] |
− | * [[Dexlansoprazole]] | + | *[[Dexlansoprazole]] |
− | * [[Esomeprazole]] | + | *[[Esomeprazole]] |
− | * [[Ilaprazole]] | + | *[[Ilaprazole]] |
− | * [[Lansoprazole]] | + | *[[Lansoprazole]] |
− | * [[Omeprazole]]<sup>#</sup> | + | *[[Omeprazole]]<sup>#</sup> |
− | * [[Pantoprazole]] | + | *[[Pantoprazole]] |
*[[Picoprazole]] | *[[Picoprazole]] | ||
− | * [[Rabeprazole]] | + | *[[Rabeprazole]] |
− | * [[Tenatoprazole]] | + | *[[Tenatoprazole]] |
*[[Timoprazole]] | *[[Timoprazole]] | ||
− | | group4 = | + | |group4= potassium-competitive acid blockers ('-prazan') |
− | | list4 = | + | |list4= |
− | * [[Linaprazan]] | + | *[[Linaprazan]] |
− | * [[Revaprazan]] | + | *[[Revaprazan]] |
− | * [[Soraprazan]] | + | *[[Soraprazan]] |
− | * [[Vonoprazan]] | + | *[[Vonoprazan]] |
− | | group5 = | + | |group5= others |
− | | | + | |list5= |
− | * [[Aceglutamide aluminum]] | + | *[[Aceglutamide aluminum]] |
− | * [[Acetoxolone]] | + | *[[Acetoxolone]] |
− | * [[Alginic acid]] | + | *[[Alginic acid]] |
− | * [[Arbaclofen placarbil]] | + | *[[Arbaclofen placarbil]] |
− | * [[Bismuth subcitrate]] | + | *[[Bismuth subcitrate]] |
− | * [[Carbenoxolone]] | + | *[[Carbenoxolone]] |
− | * [[Cetraxate]] | + | *[[Cetraxate]] |
− | * [[Gefarnate]] | + | *[[Gefarnate]] |
− | * [[Lesogaberan]] | + | *[[Lesogaberan]] |
− | * [[Pirenzepine]] | + | *[[Pirenzepine]] |
− | * [[Proglumide]] | + | *[[Proglumide]] |
− | * [[Rebamipide]] | + | *[[Rebamipide]] |
− | * [[Sucralfate]] | + | *[[Sucralfate]] |
− | * [[Sulglicotide]] | + | *[[Sulglicotide]] |
− | * [[Telenzepine]] | + | *[[Telenzepine]] |
− | * [[Teprenone]] | + | *[[Teprenone]] |
− | * [[Troxipide]] | + | *[[Troxipide]] |
− | * [[Zinc L-carnosine]] | + | *[[Zinc L-carnosine]] |
− | * [[Zolimidine]] | + | *[[Zolimidine]] |
− | | group6 = | + | |group6= combinations |
− | | | + | |list6= |
− | * [[Bismuth subcitrate/metronidazole/tetracycline]] | + | *[[Bismuth subcitrate/metronidazole/tetracycline]] |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
+ | |list7= | ||
+ | *''See also:'' [[Helicobacter pylori eradication protocols|''Helicobacter pylori'' eradication protocols]] | ||
+ | |belowstyle= background:transparent; padding:0px | ||
+ | |below= {{PharmNavFootnote}} | ||
}}<noinclude> | }}<noinclude> | ||
− | {{ | + | {{Collapsible option}} |
[[Category:Drugs for acid-related disorders]] | [[Category:Drugs for acid-related disorders]] | ||
− | [[Category:Drug templates by ATC]] | + | [[Category:Drug templates by ATC]]</noinclude> |
− | |||
− | </noinclude> |
Revision as of 16:21, 30 March 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state=
parameter may be used:
|state=collapsed
:{{Drugs for peptic ulcer and GORD|state=collapsed}}
to show the template collapsed, i.e., hidden apart from its title bar|state=expanded
:{{Drugs for peptic ulcer and GORD|state=expanded}}
to show the template expanded, i.e., fully visible|state=autocollapse
:{{Drugs for peptic ulcer and GORD|state=autocollapse}}
If the |state=
parameter in the template on this page is not set, the template's initial visibility is taken from the |default=
parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse
.